Stowarzyszenie Polskiej Grupy D/S Leczenia Białaczek u Dorosłych Palg /Polish Adult Leukemia Group/Association

Research and experimental development in natural sciences and engineering

KRS: NIP:

Overview

Status
Active
Registry date
2003-05-27
Registered address
ul. Wybrzeże Armii Krajowej 15, 44-102 Gliwice, Poland
Electronic delivery address
AE:PL-69467-94998-FEVWF-22

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 76 days late).

  • 202525/04/2026
  • 202428/04/2025
  • 202323/05/2024
  • 202230/06/2023
  • 202129/09/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 315.95kMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD -67.48kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 383.26kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 2.01mMedianUSD 278.35kAverageUSD 8.47m

Authorized Representatives

Agnieszka Wierzbowska – Management Board Member
Anna Barbara Czyż – Management Board Member
Lidia Anna Gil – Management Board Member
Joanna Drozd Sokołowska – Management Board Member
Ewa Lech Marańda – Management Board Member

Manner of representation

The management board, represented by the President and an authorised member of the management board, is authorised to acquire and dispose of property rights and to incur property liabilities on behalf of the association. The validity of decisions concerning the association’s property rights and liabilities, as well as the granting of powers of attorney, requires the signatures of the President of the management board and one of the members of the management board.

Supervisory board

Agnieszka Pluta – Supervisory Board Member
Katarzyna Budziszewska – Supervisory Board Member
Marcin Rymko – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2021-04-27.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$452
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$875
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$223

European Funds

4 EU budget awards (FTS) recorded, totalling $631,108.

ProjectEU co-financing
101136502 - Resolve - residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across europe (resolve)
$420.8K
101136502 - Resolve - residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across europe (resolve)
$173.3K
101136502 - Resolve - residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across europe (resolve)
$21,506

Change history

DateEvent
2020-07-03Address change
2011-12-15Address change
2003-05-27Entered in the register

FAQ

Last updated: 2026-04-25